| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 09/05/2016 | 20:23 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 27/04/2016 | 16:02 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 08/04/2016 | 12:03 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 12/11/2015 | 12:10 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 15/04/2015 | 17:20 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 23/03/2015 | 17:06 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt 10-k) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 07/11/2012 | 18:33 | Edgar (US Regulatory) | Quarterly Report (10-Q) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 15/08/2012 | 19:44 | Marketwired | Midday Movers on the OTCBB: HPCS, AMPW, OVIT, CSWG | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 10/07/2012 | 14:00 | Marketwired | FDA Approves OncoVista's Phase I Clinical Trial of New Drug Candidate (OVI-117) for Solid Tumors | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 30/03/2012 | 20:23 | Edgar (US Regulatory) | Annual Report (10-K) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 14/03/2012 | 17:39 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 28/11/2011 | 20:33 | Marketwired | OncoVista Innovative Therapies Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patient... | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 11/05/2011 | 13:01 | Marketwired | Report: OncoVista Positioning Itself for the Next Level | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 28/04/2011 | 20:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 10/03/2011 | 16:35 | Edgar (US Regulatory) | Current report filing (8-K) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 06/01/2011 | 16:19 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 23/12/2010 | 12:40 | Edgar (US Regulatory) | Amended Quarterly Report (10-Q/A) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 15/05/2009 | 23:16 | Edgar (US Regulatory) | Notification that Quarterly Report will be submitted late (NT 10-Q) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 09/04/2009 | 16:18 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 21/08/2008 | 20:57 | Marketwired | (OVIT.OB) OncoVista Issued $16 Price Target From Status Equity Research | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 21/08/2008 | 13:30 | Marketwired | Status Equity Research Initiates Coverage of OncoVista Innovative Therapies, Inc. (OVIT.OB) -- Long Term Target Price $16.00 | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 14/08/2008 | 22:46 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Quarterly Report (10-Q) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 17/06/2008 | 16:06 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Confidential Treatment Order (CT ORDER) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 02/05/2008 | 23:43 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Amended Current report filing (8-K/A) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 29/04/2008 | 22:26 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Current report filing (8-K) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 14/04/2008 | 23:21 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Annual Report (Small Business Issuers) (10KSB) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 31/03/2008 | 21:52 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Notification that Annual Report will be submitted late (NT 10-K) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 06/02/2008 | 17:51 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Statement of Ownership (SC 13G) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 18/01/2008 | 18:40 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
| 14/01/2008 | 12:00 | Edgar (US Regulatory) | Oncovista Innovative Therapies, Inc - Notice of Effectiveness (EFFECT) | USOTC:OVIT | OncoVista Innovative Therapies Inc (CE) |
